Consensus Hikma Pharmaceuticals PLC

Equities

HIK

GB00B0LCW083

Real-time Estimate Cboe Europe 09:59:26 2024-03-28 am EDT 5-day change 1st Jan Change
1,917 GBX +1.95% Intraday chart for Hikma Pharmaceuticals PLC +2.46% +7.29%

Evolution of the average Target Price on Hikma Pharmaceuticals PLC

Price target over the last 5 years

History of analyst recommendation changes

6711b2d44ca688810dcd.8xYGdjIjo4hy2CYw6u71lhVxevCNyVFq32fNQCXhEWE.rFlNQAUa4eA2n0Rboqq_x2ETCpv9_zkwjQ2fK2qZc0zHXEIAd3bCuyqcaw~698a505d41e98d98efe6eeb2679805c1
RBC Keeps Hikma Pharmaceuticals at Sector Perform, Raises PT MT
Barclays cuts Direct Line to equal weight AN
Barclays raises Breedon but cuts Domino's Pizza AN
HIKMA PHARMACEUTICALS : Strong Generics-led finish to 2023 Alphavalue
JPMorgan Keeps Hikma Pharmaceuticals at Overweight, Raises PT MT
Berenberg raises Moneysupermarket.com to 'buy' AN
RBC Raises Hikma Pharmaceuticals PT, Affirms Sector Perform Rating MT
Berenberg cuts target prices for miners AN
HIKMA PHARMACEUTICALS : Incorporating a healthy ongoing recovery Alphavalue
Jefferies Reduces Hikma Pharmaceuticals PT, Keeps at Hold MT
UBS cuts DS Smith; Kepler likes Genus AN
Barclays Keeps Hikma Pharmaceuticals at Equalweight, Lowers PT MT
Peel Hunt raises Flutter to 'buy' from 'hold' AN
JPMorgan Trims Hikma Pharmaceuticals PT, Keeps Overweight Rating MT
Goldman lifts Landsec and British Land AN
Jefferies Downgrades Hikma Pharmaceuticals to Hold from Buy, Trims PT MT
Hikma's Generics Recovery Remains Uncertain Despite Upgraded Outlook, Berenberg Says MT
Watches of Switzerland impresses HSBC; Asos cut AN
HIKMA PHARMACEUTICALS : Healthy Q3; Injectables’ temporary constraints shouldn’t be a worry Alphavalue
JPMorgan lifts Smith & Nephew AN
FTSE 100 Closes Up After Bank of England Holds Off Rate Rise DJ
EMEA Morning Briefing: Stocks Seen Higher Ahead of BOE Rate Decision DJ
All hail the resilience of the US economy Our Logo
ANALYST RECOMMENDATIONS : Adobe, Live Nation, Meta, Snap, Wpp... Our Logo
The FTSE 100 Closed Down as the Prospect of Rates Staying High for Longer Solidifies DJ
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
23.74 USD
Average target price
29.18 USD
Spread / Average Target
+22.89%
High Price Target
35.33 USD
Spread / Highest target
+48.80%
Low Price Target
23.73 USD
Spread / Lowest Target
-0.05%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Hikma Pharmaceuticals PLC

RBC Capital Markets
alphavalue Abhishek Raval
JPMorgan
Jefferies & Co.
Barclays
Berenberg Bank
Morgan Stanley
Goldman Sachs
Citigroup
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Quarterly revenue - Rate of surprise